Şunu aradınız:: siol (Litvanca - İngilizce)

per dien 5 dienas iki siol neistirtas
decelerates uptake of amoxicillin

at ir bi mediana iki siol nepasiekta.
26.8% ­ 47.5%) the median dr and os had not yet been reached.

iki siol negauta duomen apie toki sveik.
accordingly, to date there has been no indication of such interactions.

sergamumo ir mirtingumo tyrimai iki siol nebaigti.
studies on morbidity and mortality have not yet been terminated.

vis dlto stebtos sveikos mechanizmas iki siol nezinomas.
however, the mechanism of the observed interaction is presently unknown.

dynepo sveikos su kitais vaistais iki siol nepastebta.
however, so far, no interactions with other medicines have been reported during treatment with dynepo.

iki siol tyrimuose su gyvnais teratogeninio repaglinido poveikio nestebta.
up to now repaglinide showed not to be teratogenic in animal studies.

iki siol nra zinoma sveikos su kitais vaistiniais preparatais atvej.
no interactions with other medicinal products are currently known.

vis dlto poveikio, skatinancio vaisiaus apsigimim, iki siol nepastebta.
however, to date, no particular malformative effect has been reported.

bendrojo isgyvenamumo mediana tyrimo metu nei vienoje tiriamojoje grupje iki siol nepasiekta.
median overall survival had not yet been reached in either treatment arm at the time of analysis.

aptivus jums vartoti draudziama, jei js niekada iki siol nevartojote antiretrovirusini preparat.
aptivus treatment should not be used if you have never received antiretroviral therapy (treatment-naïve) .

nstumas ligi siol sukauptais duomenimis, vartojant vaist nstumo metu, rizika nepadidja.
information collected to date does not indicate a increased risk when used during pregnancy.

taciau iki siol dl nepakankamai turim duomen specifiniai pavojai, gresiantys negimusiam kdikiui, nenustatyti.
however, so far the available data are insufficient and do not identify specific risks for the unborn child.

klinikinio tyrimo, tsiamo iki siol, metu gydymas glivec buvo tsiamas iki ligos progresavimo (zr.
in the only clinical trial performed up to now, treatment with glivec was continued until disease progression (see section 5.1) .